Bottom line
How much do MEDX and IYH overlap?
48% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 50.1% of MEDX's assets and 47.1% of IYH's. They share a meaningful core but differ in the rest of the portfolio.
IYH holds far more positions (103 vs 33), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings MEDX and IYH have in common
| Holding | % of MEDX | % of IYH | Overlap |
|---|---|---|---|
| Eli Lilly & Co LLY | 18.46% | 15.11% | 15.11% |
| AbbVie Inc ABBV | 8.85% | 7.32% | 7.32% |
| Johnson & Johnson JNJ | 5.59% | 10.17% | 5.59% |
| Bristol-Myers Squibb Co BMY | 4.42% | 2.20% | 2.20% |
| Merck & Co Inc MRK | 3.96% | 5.31% | 3.96% |
| Amgen Inc AMGN | 3.91% | 3.42% | 3.42% |
| Pfizer Inc PFE | 2.86% | 2.35% | 2.35% |
| Regeneron Pharmaceuticals Inc REGN | 2.06% | 1.27% | 1.27% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in MEDX
- US Bank Mmda - Usbgfs 7 — 9.19%
- Novartis AG — 6.89%
- Alkermes PLC — 5.53%
- AstraZeneca PLC — 4.98%
- Ionis Pharmaceuticals Inc — 4.53%
- Alnylam Pharmaceuticals Inc — 3.42%
- Biogen Inc — 3.09%
- Gsk Plc — 2.71%
- CRISPR Therapeutics AG — 2.64%
- Beam Therapeutics Inc — 1.51%
- Galectin Therapeutics Inc — 1.14%
- Intellia Therapeutics Inc — 1.12%
- Sandoz Group AG — 0.80%
- Replimune Group Inc — 0.73%
- Vanda Pharmaceuticals Inc — 0.73%
Only in IYH
- Unitedhealth Group Incorporated — 6.16%
- Thermo Fisher Scientific Incorporated — 3.52%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Intuitive Surgical, Inc. — 2.05%
- Danaher Corporation — 2.03%
- Vertex Pharmaceuticals Incorporated — 2.00%
- Stryker Corporation — 1.86%
- Medtronic Public Limited Company — 1.80%
- Elevance Health, Inc. — 1.34%
- The Cigna Group — 1.20%
- Boston Scientific Corporation — 1.14%
- Hca Healthcare, Inc. — 0.99%
- Edwards Lifesciences Corporation — 0.81%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 0.80%
Asset mix
| Asset type | MEDX | IYH |
|---|---|---|
| Stocks | 92.6% | 99.8% |
| Cash & short-term funds | 9.2% | 0.9% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | MEDX | IYH |
|---|---|---|
| US | 77.4% | 97.3% |
| CH | 10.3% | — |
| GB | 8.6% | 0.4% |
| IE | 5.5% | 2.4% |
| BM | — | 0.3% |
| DK | — | 0.2% |
| NL | — | 0.1% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do MEDX and IYH overlap?
What stocks do MEDX and IYH have in common?
Should I own both MEDX and IYH?
Which holds more stocks, MEDX or IYH?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.